Document:

Exhibit 10.2

 

RELEASE AGREEMENT

 

This Release Agreement (“Agreement”)
is made as of July 13, 2022 by and among (i) Innoviva, Inc., a Delaware corporation (“Innoviva”),
(ii) Innoviva TRC Holdings LLC, a Delaware limited liability company (“Innoviva Seller”), (iii) Royalty Pharma
Investments 2019 ICAV, an Irish collective asset-management vehicle (the “Purchaser”), (iv) Theravance Respiratory
Company, LLC, a Delaware limited liability company (the “Company”), (v) Theravance Biopharma, Inc., a Cayman
Islands exempted company (“Theravance”) and (vi) Theravance Biopharma US Holdings, Inc., a Delaware corporation
(“Theravance US Holdings”) and Triple Royalty Sub II LLC, a Delaware limited liability company (“Triple II”
and together with Theravance US Holdings, the “Theravance Equity Holders”). Each of the persons and entities referenced
in the preceding sentence may be referred to herein collectively as the “parties” and individually as a “party.”

 

WHEREAS, Innoviva is
the indirect record and beneficial owner through its subsidiary, Innoviva Seller, of 750 Class A Units and 750 Class C
Units of the Company (the “Innoviva Equity”).

 

WHEREAS, Theravance is the
indirect record and beneficial owner through its subsidiaries, the Theravance Equity Holders, of 2,125 Class B Units and 6,375 Class C
Units of the Company (the “Theravance Equity”).

 

WHEREAS, Innoviva has
agreed to cause the Innoviva Seller to sell to the Purchaser, and the Purchaser has agreed to purchase from the Innoviva Seller, the Innoviva
Equity pursuant to that certain Equity Purchase Agreement dated as of the date hereof by and among the Innoviva Seller, the Purchaser,
and, for purposes of certain provisions therein, Innoviva (the “Innoviva EPA”).

 

WHEREAS, Theravance has agreed
to cause the Theravance Equity Holders to sell to the Purchaser, and the Purchaser has agreed to purchase from Theravance and the Theravance
Equity Holders, the Theravance Equity pursuant to that certain Equity Purchase Agreement dated as of the date hereof by and between Theravance
and the Purchaser (the “Theravance EPA”).

 

WHEREAS, to facilitate the
sale and effect the transfer of the Innoviva Equity under the Innoviva EPA and the Theravance Equity under the Theravance EPA, the parties
hereby enter into this Release Agreement as a condition precedent of the transactions contemplated under the Innoviva EPA and the Theravance
EPA.

 

NOW THEREFORE, in consideration
of the mutual promises and releases contained herein and for other good and valuable consideration, the sufficiency of which is hereby
acknowledged, the parties agree as follows:

 

     

     

    

 

1.     Release.
Subject to, and effective upon, the closing of the transactions contemplated by the Innoviva EPA and the Theravance EPA (the “Closing”),
each of the parties hereto, on behalf of itself and each of its affiliates and subsidiaries (collectively, the “Releasing Parties”),
hereby unconditionally and forever releases, waives and discharges all claims, actions, causes of action, choses in action, suits, debts,
damages, dues, sums of money, accounts, reckonings, bonds, bills, specialties, variances, trespasses, judgments, remedies, rights of set-off,
third-party claims, subrogation claims, contribution claims, reimbursement claims, indemnity claims, counterclaims, and crossclaims, whether
known or Unknown Claims, liquidated or unliquidated, fixed or contingent, matured or unmatured, disputed or undisputed, whether direct,
indirect, derivative, or otherwise, and whether arising in law, equity or otherwise (collectively, “Causes of Action”)
that could have been, or may be, asserted by or on behalf of such Releasing Party against each of the other parties hereto and the affiliates
or subsidiaries of each of such other parties and the respective current and former officers, managers, affiliates, subsidiaries, partners,
directors, employees, agents, members, shareholders, securities holders, note holders, advisors and professionals (including any attorneys,
accountants, consultants, financial advisors, investment bankers and other professionals retained by such persons) of such other parties
and the affiliates and subsidiaries thereof, together with their respective successors and assigns, each solely in its capacity as such
(collectively, the “Released Parties”), that are based in whole or in part on any act, omission, transaction, event,
occurrence or facts or circumstances taking place, being omitted, existing or otherwise arising prior to the Closing in any way relating
to the Company or the business, investing activity or operations thereof or the ownership of the Innoviva Equity or the Theravance Equity
(the “Released Claims”). Notwithstanding the foregoing, (1) none of Innoviva, Innoviva Seller, their respective
affiliates or subsidiaries and their respective current and former officers, managers, affiliates, subsidiaries, partners, directors,
employees, agents, members, shareholders, securities holders, note holders, advisors and professionals (including any attorneys, accountants,
consultants, financial advisors, investment bankers and other professionals retained by such persons) or the Purchaser, its affiliates
or subsidiaries and its current and former officers, managers, affiliates, subsidiaries, partners, directors, employees, agents, members,
shareholders, securities holders, note holders, advisors and professionals (including any attorneys, accountants, consultants, financial
advisors, investment bankers and other professionals retained by such persons) (the “Purchaser Released Parties”) shall
be released pursuant to this Section 1 from any Cause of Action arising under the express terms of the Innoviva EPA (or any
certificate, document or instrument (including this Agreement) delivered thereunder or in connection therewith); and (2) none of
Theravance, Theravance Equity Holders, their respective affiliates or subsidiaries and their respective current and former officers, managers,
affiliates, subsidiaries, partners, directors, employees, agents, members, shareholders, securities holders, note holders, advisors and
professionals (including any attorneys, accountants, consultants, financial advisors, investment bankers and other professionals retained
by such persons) or the Purchaser Released Parties shall be released pursuant to this Section 1 from any Cause of Action arising
under the express terms of the Theravance EPA (or any certificate, document or instrument (including this Agreement) delivered thereunder
or in connection therewith).

 

“Unknown Claims” means claims
which the Releasing Parties do not know or suspect to exist in their favor at the time of the release of the Released Parties, including
any such claims which, if known by them might have affected their release of the Released Parties, or might have affected their decision(s) with
respect to this Agreement. With respect to any and all Released Claims, the Releasing Parties stipulate and agree that they expressly
waive, the provisions, rights, and benefits of California Civil Code §1542, which provides:

 

A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor
at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor
or released party.

 

    2

     

    

 

The Releasing Parties waive any and all provisions, rights, and benefits conferred by any law of any state or territory of the United
States, or principle of common law, which is similar, comparable, or equivalent to California Civil Code §1542. The Releasing Parties
acknowledge that they may hereafter discover facts in addition to or different from those which they now know or believe to be true with
respect to the subject matter of the Released Claims, but expressly fully, finally, and forever waive, compromise, settle, discharge,
extinguish and release fully, finally, and forever, any and all Released Claims, known or unknown, suspected or unsuspected, contingent
or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed, upon any theory of law or equity
now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or
without malice, or a breach of any duty, law or rule, without regard to the subsequent discovery or existence of such different or additional
facts, legal theories, or authorities. The Releasing Parties acknowledge that the foregoing waiver was separately bargained for and is
an essential element of the Agreement of which this release is a part.

 

2.     Consent.
Innoviva and Innoviva Seller hereby expressly agree that, notwithstanding anything to the contrary in the Theravance Respiratory Company,
LLC Company Agreement, dated as of May 31, 2014 (the “LLC Agreement”), the Class B Units of the Company will
continue to have the rights set forth in Section 5.4(c) of the LLC Agreement notwithstanding the transfer thereof pursuant to
the Theravance EPA. Theravance and Theravance Equity Holders hereby expressly consent to, subject to, and effective upon, the Closing,
the transfer of the Innoviva Equity to the Purchaser and the distribution of 100% of the investments held by the Company, as set forth
on Exhibit A attached hereto, to Innoviva or Innoviva Seller (provided, however, that the cash balance on the Company’s
Cash Distribution Report as of July 2022 attached hereto as Exhibit B has remained, and shall remain, unchanged).

 

3.     Counterparts;
Electronic Signatures. This Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts,
each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.
Copies of executed counterparts transmitted by telecopy, facsimile or other similar means of electronic transmission, including “PDF”
or DocuSign, shall be considered original executed counterparts, provided receipt of such counterparts is confirmed.

 

4.     Governing
Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York without giving effect
to any choice or conflict of law provision or rule that would cause the application of the laws of any other jurisdiction.

 

		5.	Consent to Jurisdiction; Waiver of Jury Trial.

 

a.     EACH
OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS RESPECTIVE PROPERTY AND ASSETS, TO THE EXCLUSIVE
JURISDICTION OF ANY NEW YORK STATE COURT OR FEDERAL COURT OF THE UNITED STATES OF AMERICA SITTING IN NEW YORK COUNTY, NEW YORK, AND ANY
APPELLATE COURT THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR FOR RECOGNITION OR ENFORCEMENT
OF ANY JUDGMENT IN RESPECT THEREOF, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY AGREE THAT ALL CLAIMS IN RESPECT OF
ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO HEREBY AGREE THAT A NON-APPEALABLE FINAL JUDGMENT IN ANY SUCH ACTION
OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED
BY APPLICABLE LAW. EACH OF THE PARTIES HERETO HEREBY SUBMITS TO THE EXCLUSIVE PERSONAL JURISDICTION AND VENUE OF SUCH NEW YORK STATE AND
FEDERAL COURTS.

 

b.     EACH
OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT IT MAY LEGALLY AND EFFECTIVELY DO SO,
ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO
THIS AGREEMENT IN ANY NEW YORK STATE OR FEDERAL COURT. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.

 

    3

     

    

 

c.     EACH
OF THE PARTIES HERETO HEREBY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER
DOCUMENT DELIVERED HEREUNDER OR IN CONNECTION HEREWITH, OR ANY TRANSACTION ARISING FROM OR CONNECTED TO ANY OF THE FOREGOING. EACH OF
THE PARTIES HERETO REPRESENTS THAT THIS WAIVER IS KNOWINGLY, WILLINGLY, AND VOLUNTARILY GIVEN.

 

6.     Severability.
In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable
or void, this Agreement shall continue in full force and effect without said provision; provided that no such severability shall be effective
if it materially changes the economic benefit of this Agreement to any party.

 

7.     Amendments
or Modifications. This Agreement may not be amended or modified except by a written instrument signed by each of the parties hereto;
provided that any party may agree with one or more other parties to amend or modify this Agreement by and among themselves so long as
such amendment or modification does not affect the rights of any other parties.

 

8.     Successors;
Third Party Beneficiary. This Agreement is intended to bind, and inure to the benefit of, the parties and each of their respective
successors, assigns, heirs, executors, administrators and representatives. However, neither this Agreement nor any rights or obligations
hereunder may be assigned without the prior written consent of the other parties. All persons and entities that are released pursuant
to Section 1 hereof shall be third party beneficiaries of this Agreement with the right to enforce the same as if they were
direct parties hereto. Except as provided herein, no person or entity has the right to enforce or shall enjoy the benefit of the terms
and provisions of this Agreement.

 

9.     Remedies;
Miscellaneous. It is understood and agreed by each of the parties that any breach of this Agreement would give rise to irreparable
harm for which money damages would not be an adequate remedy and accordingly it is agreed that, in addition to any other remedies, each
person or entity released pursuant to Section 1 of this Agreement shall be entitled to specific performance and injunctive
or other equitable relief, without the necessity of posting a bond, for any such breach. Each of the parties acknowledges that it has
been represented by counsel (or had the opportunity to be so represented and waived its right to do so) in connection with this Agreement
and the transactions contemplated hereby. Accordingly, any rule of law or any legal decision that would provide any party with a
defense to the enforcement of the terms of this Agreement against such party based upon lack of legal counsel shall have no application
and is expressly waived. No party shall have any term or provision construed against such party solely by reason of such party having
participated in the drafting of such provision.

 

[Signature page follows]

 

    4

     

    

 

IN WITNESS WHEREOF, the parties
hereto have executed this Release Agreement as of the date first set forth above.

 

 

	 	 	INNOVIVA, INC.
	 	 	 
	 	 	By:	/s/ Pavel Raifeld
	 	 	 	Name: Pavel Raifeld
	 	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	INNOVIVA TRC HOLDINGS LLC
	 	 	 
	 	 	By:	Innoviva, Inc. (its managing member)
	 	 	 
	 	 	By:	/s/ Pavel Raifeld
	 	 	 	Name: Pavel Raifeld
	 	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	ROYALTY PHARMA INVESTMENTS 2019 ICAV
	 	 	 
	 	 	By:	RP Management, LLC, its Manager and lawfully appointed attorney
	 	 	 
	 	 	By:	/s/ George Lloyd
	 	 	 	Name: George Lloyd
	 	 	 	Title: EVP, Investments & General Counsel
	 	 	 
	 	 	THERAVANCE RESPIRATORY COMPANY, LLC
	 	 	 
	 	 	By:	/s/ Pavel Raifeld
	 	 	 	Name: Pavel Raifeld
	 	 	 	Title: Chief Executive Officer

 

[Release
Agreement]

 

     

     

    

 

	 	 	THERAVANCE BIOPHARMA, INC.
	 	 	 
	 	 	By:	/s/ Rick E Winningham
	 	 	 	Name: Rick E Winningham
	 	 	 	Title: Chief Executive Officer
	 	 	 	 
	 	 	Theravance
Biopharma US Holdings, Inc. 

	 	 	 	 
	 	 	By:	/s/ Rick E Winningham
	 	 	 	Name: Rick E Winningham
	 	 	 	Title: Chief Executive Officer
	 	 	 	 
	 	 	Triple
Royalty Sub II LLC 

	 	 	 	 
	 	 	By:	/s/ Rick E Winningham
	 	 	 	Name: Rick E Winningham
	 	 	 	Title: Chief Executive Officer

 

[Release Agreement]

 

     

     

    

 

Exhibit A

 

Company Investments

 

     

     

    

 

Exhibit B

 

Company Cash Distribution Report as of July 2022

 

[See attached.]Exhibit
10.3

 

Exclusive
Management Consulting and Service Agreement

 

This
exclusive management consulting and service agreement (hereinafter referred to as the Agreement) is entered into by and between the following
two parties in Longquanyi District, Chengdu City, Sichuan Province, China on 3rd December, 2020.

 

	1.	Chengdu
    Jiulin Ke Fu Technological Co., Ltd. (hereinafter referred to as “Company A”) 
	 	 
	 	Registered
    address: No. 5#(3), 5thFloor, D2 Building, No. 1666, Section 2, Chenglong Avenue, Chengdu Economic and Technological Development
    Zone, Sichuan, China.
	 	 
	 	The
    unified social credit code: 91510112MA63FAPN76
	 	 
	2.	Sichuan
    Hengguang Insurance Agency Co., Ltd. (hereinafter referred to as “Company B”) 
	 	 
	 	Registered
    address: No. 1666, Section 2, Chenglong Avenue, Chengdu Economic and Technological Development Zone (Longquanyi District), Sichuan,
    China.
	 	 
	 	The
    unified social credit code: 91510112762336643W

 

Whereas:

 

	 	(1)	As
    a solely foreign-owned enterprise with investors from Hong Kong, Macao and Taiwan and established in the People’s Republic
    of China (hereinafter referred to as “China”), Company A is equipped with a team which provides enterprise management
    consulting and planning services. 
	 	 	 
	 	(2)	Funded
    by domestic shareholders, Company B is a limited company registered in China; 
	 	 	 
	 	(3)	Company
    A may provide development strategy, application scheme of insurance agency and related services to Company B; Company B consents
    to accept the technical consultation and services provided by Company A in accordance with the terms and conditions made herein.
    

 

    	1/17

    	 

    

 

Hereby
after negotiation, both parties reach the agreement as follows:

 

	1.	Management
    Planning and Consulting Services: Exclusive Rights and Interests 

 

	 	1.1.	During
    the term of the Agreement, Company A consents to serve as the management consulting and service provider of Company B according to
    the terms hereof, providing Company B with management consulting and services (see Annex 1 for details) of information application
    and daily operation ((hereinafter referred to as “target business”) for its development strategy and insurance agency’s
    products on related platforms. 
	 	 	 
	 	1.2.	Company
    B gives consent to receive the management consulting and planning services provided by Company A and it further agrees that it shall
    not accept the same or similar consultation and services provided by any third party for the target business hereinabove during the
    term hereof unless with Company A’s prior written consent.

 

	2.	Calculation
    and Payment of Management Consulting and Service (hereinafter referred to as “consulting service fee”)

 

	 	The
    two parties agree that the consulting service fee herein shall be determined and paid in the way regarding the Agreement listed in
    Annex 2.

 

    	2/17

    	 

    

 

	3.	Intellectual
    Property Rights and Licensing 

 

	 	3.1.	Ownership and licensing (intellectual property rights formed
by management consulting and service)

 

	 	 	(A)
    The two parties confirm that Company A is the exclusive owner of all rights and benefits generated from the implementation of the
    Agreement, including but not limited to trademark rights, software copyright, enterprise development strategy, technical information
    (data), proprietary technology (including technical know-how/secrets), management system, patent rights, trade secrets, copyright
    (if any) and other intellectual property rights related to the service provided, whether developed by Company A or developed by Company
    B on the basis of Company A’s previous intellectual property rights.
	 	 	 
	 	 	(B)
    The two parties warrant that Company B shall sign up all documents and take all actions required to make Company A the owner of such
    intellectual property. Company B shall not challenge Company A’s ownership of all intellectual property hereinabove. Any application
    for registration or other acquisition of any such intellectual property by Company B shall be subject to the prior written consent
    of Company A.
	 	 	 
	 	 	(C)
    Company A may grant Company B a non-exclusive right to utilize the intellectual property mentioned in article 3.1 on the condition
    that the content, purpose and scope of the intellectual property used by Company B shall be subject to the prior written consent
    of Company A. The licensed intellectual property hereinabove shall be a paid and revocable authorization. Any matters related to
    the above license shall be specified in a separate agreement signed by both parties and the grant of such license shall not result
    in the transfer of any intellectual property rights or any restriction on Company A’s exercise of its full ownership over all
    such intellectual property. Without the prior written consent of Company A’s, the intellectual property license granted to
    Company B shall not be transferred or sublicensed by Company B to any third party.

 

    	3/17

    	 

    

 

	 	3.2.	Exclusive
    license (intellectual property under the name of Company B)

 

	 	Both parties agree that
  Company A is hereby irrevocably authorized to enjoy the exclusive utilization and benefit rights of all intellectual property
  whether currently or in the future belongs to Company B, including but not limited to copyright in computer software [HengKuaiBao
  insurance software (hereinafter referred to as “HengKuaiBao”), YouHuiBao insurance software ((hereinafter referred to as
  “YouHuiBao”)], proprietary technology (APP application technology of Hengguang insurance agency, information management
  of its operation platform and other technical know-how/secrets), trademark right and trademark application rights, technical
  information (data), company domain over the internet, trade secret (customer classification management, overall solution of
  insurance business agency, etc.), patent right, copyright and other intellectual property rights.

 

	4.	Responsibilities
    of Both Parties

 

	 	4.1.	Responsibilities
    of Company A
	 	 	 
	 	 	In
    addition to the responsibilities specified in other terms hereof, Company A shall undertake the following responsibilities as well:

 

	 	(a)	Provide
    support services for content specified in article 1 hereinabove to Company B in an effective manner, and respond to the request for
    advice and assistance from Company B timely and seriously;
	 	 	 
	 	(b)	Assist
    Company B to prepare business plans related to target business;
	 	 	 
	 	(c)	Assist
    Company B to plan, design, develop and implement target business;
	 	 	 
	 	(d)	Provide
    competent personnel for Company B to perform the services under the Agreement;
	 	 	 
	 	(e)	 Full
     fill the obligations under the Agreement and any other related
    contracts to which it is a party.

 

    	4/17

    	 

    

 

	 	4.2.	Responsibilities
    of Company B
	 	 	 
	 	 	In
    addition to the responsibilities specified in other terms hereof, Company B shall undertake the following responsibilities as well:

 

	 	(a)	Not
    accept the same or similar support services provided by any third party without the prior written consent of Company A;
	 	 	 
	 	(b)	Accept
    all support services provided by Company A and all reasonable opinions related to the support services;
	 	 	 
	 	(c)	Formulate
    business plans under the assistance of Company A;
	 	 	 
	 	(d)	Prepare,
    design, develop, establish and perform target business under the assistance of Company A;
	 	 	 
	 	(e)	Provide
    Company A with any management consultation or other information and allow it to enter into the relevant facilities that Company A
    considers necessary or useful for providing the services under the Agreement;
	 	 	 
	 	(f)	Establish
    and maintain an independent unit of account for target business;
	 	 	 
	 	(g)	Operate
    target business and other business of Company B strictly in accordance with business plans and decision jointly made by the two parties;
    

 

    	5/17

    	 

    

 

	 	(h)	Intention
    to sign a significant contract with any third party shall obtain the written consent of Company A before signing the contract; a
    significant contract refers to a written or oral contract, agreement or commitment entered into with any third party, whether it
    be cooperation, equity transfer, funding or any other form which may affect the interests of Company A in the Agreement or may cause
    Company A to make any change or terminate the Agreement in advance;
	 	 	 
	 	(i)	Provide
    and manage target business in an effective, prudent and legal manner so as to obtain the maximum benefits;
	 	 	 
	 	(j)	Assist
    and fully cooperate with Company A in all matters necessary for it to effectively perform its duties and obligations under the Agreement;
    
	 	 	 
	 	(k)	Report
    all contacts with the market regulatory authorities to Company A, and timely provide it with copies of all documents, licenses, consents
    and authorizations obtained from relevant market regulatory authorities; 
	 	 	 
	 	(l)	Assist
    Company A to develop, establish and maintain relations with other pertinent departments, authorities and other entities of China’s
    central, provincial and local governments, and assist Company A to obtain all necessary permits, licenses, consents and authorizations
    for the services hereinabove;
	 	 	 
	 	(m)	Assist
    Company A in handling the duty-free import procedures of all assets, materials and supplies required by Company A to provide services
    herein;
	 	 	 
	 	(n)	Assist
    Company A in purchasing equipment, materials, supplies, labor and other services in China that meet the requirements of Company A
    at competitive prices 

 

    	6/17

    	 

    

 

	 	(o)	Conduct
    business in accordance with all pertinent Chinese laws and regulations and go through all necessary procedures related to business
    operation;
	 	 	 
	 	(p)	Provide
    Company A with copies of relevant laws, regulations, decrees and rules of China and other relevant materials required by Company
    A;
	 	 	 
	 	(q)	 Full
     fill the obligations under the Agreement and any other related
    contracts to which it is a party.

 

	5.	Representation
    and Warranty 

 

	 	5.1.	Company
    A hereby represents and warrants as follows: 

 

	 	(a)	Company
    A is legally established and validly exists in accordance with the laws of China;
	 	 	 
	 	(b)	Company
    A signs and performs the Agreement within its ability and business scope: it has taken necessary actions and appropriate authorization
    and obtained the consent and approval of the third party as well as pertinent government departments. In addition, it does not violate
    the restrictions of pertinent laws and contracts. 
	 	 	 
	 	(c)	Once
    signed, the Agreement shall constitute the legal, valid and binding obligations of Company A, which can be enforced in accordance
    with the terms hereof. 

 

	 	5.2.	Company
    B hereby represents and warrants as follows: 

 

	 	(a)	Company
    B is legally established and validly exists in accordance with the laws of China;

 

    	7/17

    	 

    

 

	 	(b)	Company
    B signs and performs the Agreement within its ability and business scope: it has taken necessary actions and appropriate authorization
    and obtained the consent and approval of the third party as well as pertinent government departments. In addition, it does not violate
    the restrictions of pertinent laws and contracts. 
	 	 	 
	 	(c)	Once
    signed, the Agreement shall constitute the legal, valid and binding obligations of Company B, which can be enforced in accordance
    with the terms hereof. 

 

	6.	Confidentiality
    Clause 

 

	 	6.1.	Company
    B agrees to employ all reasonable confidentiality measures to keep confidential the confidential materials and information (hereinafter
    referred to as “confidential information”) that it knows or comes into contact with as a result of receiving the exclusive
    consultation and services of Company A; without the prior written consent of company A, company B shall not disclose, accord or assign
    such confidential information to any third party. Once the Agreement is terminated, Company B shall hand over any document, material
    or software containing the confidential information to Company A at the request of Company A, or eliminate, at the option of Company
    B, such confidential information. Company B shall delete the confidential information from any relevant memory device and shall not
    continue to use such information.
	 	 	 
	 	6.2.	Both
    parties agree that the confidentiality clause shall remain in force whether or not the Agreement is changed, rescinded or terminated.

 

    	8/17

    	 

    

 

	7.	Liability for Breach of Contract and Compensation

 

	 	7.1.	Liability
    for breach of contract
	 	 	 
	 	 	Both
    parties agree and confirm that if either party (the breaching party) substantially violates any article herein, or substantially
    fails to perform or delays in performing any obligation under the Agreement, it constitutes a breach hereof (the breach), and the
    non-breaching party (the observant party) has the right to require the breaching party to make rectification or take remedial measures
    within a reasonable period of time. If the breaching party fails to rectify or take remedial measures within a reasonable period
    of time or within ten (10) days after the observant party gives a written notice to the breaching party and puts forward the request,
    the observant party has the right to claim compensation from the breaching party for damages. 
	 	 	 
	 	7.2.	Compensation
    
	 	 	 
	 	 	Company
    B shall fully compensate Company A for any loss, damage, obligation and/or expense caused by any lawsuit, claim or other request
    against Company A from the contents of the consultation and services required by Company B; Company B shall protect Company A from
    any damage and loss caused by the act of Company B or any third party at the request of Company B.

 

	8.	Effective
    Date and Validity Period

 

	 	8.1.	The
    Agreement is signed on the date indicated at the beginning of the Agreement and shall come into force right upon the signature. It
    shall remain effective for ten (10) years unless terminated in advance and in accordance with the terms hereof or relevant agreement
    signed by both parties. 
	 	 	 
	 	8.2.	The
    Agreement shall be automatically extended for ten (10) years upon expiration, unless otherwise agreed in written agreement.

 

    	9/17

    	 

    

 

	9.	Termination
    

 

	 	9.1.	Expiration
    termination
	 	 	 
	 	 	The
    Agreement shall terminate on the expiration date unless otherwise renewed in accordance with relevant provisions hereof. 
	 	 	 
	 	9.2.	Premature
    termination 
	 	 	 
	 	 	During
    the term of the Agreement, Company B shall not terminate the Agreement in advance unless Company A has gross negligence, fraud, other
    illegal acts, bankruptcy, dissolution or termination by operation of law; the Agreement will be terminated if Company B bankrupts
    or dissolves by operation of law before the expiration date hereof. Company A shall always have the right to terminate the Agreement
    at any time by giving a written notice to Company B 30 days in advance.
	 	 	 
	 	9.3.	Terms
    after termination
	 	 	 
	 	 	After
    the termination hereof, the rights and obligations of both parties under article 5 and article 6 shall remain in force.

 

	10.	Applicable
    Law and Dispute Resolution 

 

	 	10.1.	Applicable
    law
	 	 	 
	 	 	The
    Agreement shall be governed by the laws of China in terms of its formation, validity, interpretation, performance and the settlement
    of disputes under the Agreement. 

 

    	10/17

    	 

    

 

	 	10.2.	Dispute
    resolution. 
	 	 	 
	 	 	Any
    dispute caused by the interpretation and performance hereof shall be settled at first by both parties through amicable negotiation.
    If the dispute cannot be settled within thirty (30) days after one party sends a written notice to the other party, either party
    may file a lawsuit to the people’s court with jurisdiction in the place where the Agreement is signed.

 

	11.	Change
    In Law

 

	 	 	After
    the Agreement comes into effect, if any central or local legislative or administrative organ in China modifies its terms of any laws,
    regulations, rules or other normative documents, including the amendment, supplement or repeal of existing laws, regulations, rules
    or other normative documents, the interpretation and promulgation of implementation measures and rules of existing laws, regulations,
    rules or other normative documents (collectively referred to as amendments), or the promulgation of new laws, regulations, rules
    or other normative documents (collectively referred to as new provisions), the following shall apply:

 

	 	11.1.	If
    the revised or newly implemented provisions are more beneficial to either party than the relevant laws, regulations, rules or other
    normative documents in force on the effective date of the Agreement (and the other party is not seriously and negatively affected),
    both parties shall promptly apply for the benefits of the revised or newly implemented provisions from the relevant authorities (if
    necessary). Both parties shall make their best efforts to obtain approval of the application.
	 	 	 
	 	11.2.	If
    the economic interests of Company A under the Agreement are directly or indirectly negatively affected due to the amendments or new
    provisions of related laws, regulations, rules or other normative documents, and both parties are unable to solve the adverse effects
    on the economic interests of Company A in accordance with the provisions hereof, both parties shall make all necessary amendments
    hereto through timely consultation after Company A informs Company B, so as to maintain the economic interests of Company A to the
    maximum extent under the Agreement.

 

    	11/17

    	 

    

 

	12.	Force
    Majeure 

 

	 	12.1.	Force
    majeure event refers to any event beyond the reasonable control of one party, which remains unavoidable even under appropriate attention
    of the affected party, including but not limited to natural disasters (fire, flood, rainstorm above category 8 and other extreme
    weather), accidents [public health emergencies (including home quarantine caused by pandemic or other epidemic or administrative
    orders issued by the provincial government of Sichuan Province/municipal government of Chengdu City)], wars, riots, etc.. However,
    lack of credit, funds or financing shall not be regarded as beyond the reasonable control of a party. If the performance of the Agreement
    is delayed or hindered by any force majeure event, the party affected by the force majeure shall bear no responsibility under the
    Agreement in respect of such delayed or hindered performance. The party affected by force majeure event that desires to exempt from
    the performance of its obligations under the Agreement or any term of the Agreement shall notify the other party of such exemption
    at the earliest possible time and inform the other party of the steps it may take to complete the performance.
	 	 	 
	 	12.2.	The
    party affected by force majeure event bears no liability under the Agreement only on the basis that the affected party makes appropriate
    efforts to perform the Agreement and with the efforts hereinabove, the affected party may seek for exemption from the obligation
    limited to the delayed or hindered performance. Once the force majeure event for such exemption is rectifiable and remedial, both
    parties agree to execute their best efforts to resume performance under the Agreement.

 

    	12/17

    	 

    

 

	13.	Others
    

 

	 	13.1.	Notice
    
	 	 	 
	 	 	Notices
    under the Agreement shall be sent by hand, fax or registered mail. If the notice is sent by registered mail, the date of receipt
    recorded on the return receipt of the registered mail shall be the date of service; if it is sent by hand or fax, the date of sending
    shall be the date of service. If it is sent by fax, the original shall be sent by registered mail or delivered by hand immediately
    after sending.
	 	 	 
	 	13.2.	Further
    assurance
	 	 	 
	 	 	Both
    parties agree to promptly sign such documents and take such further actions as are reasonably necessary for the implementation of
    the provisions and the realization of the goals hereof.
	 	 	 
	 	13.3.	Complete contract
	 	 	 
	 	 	The
    Agreement constitutes the complete contract between the two parties on the subject matter hereof, except for the written amendments,
    supplements or modifications made after the signing of the Agreement, and it supersedes all oral or written negotiations, representations
    and contracts on the subject matter hereof reached before.
	 	 	 
	 	13.4.	Heading
	 	 	 
	 	 	Headings
    of the Agreement are for convenience only and shall not be employed to interpret, explain or otherwise affect the meaning of the
    provisions hereof.
	 	 	 
	 	13.5.	Tax
    
	 	 	 
	 	 	All
    taxes and expenses incurred by each party as a result of the signing and performance hereof shall be borne by each party separately.

 

    	13/17

    	 

    

 

	 	13.6.	Assignment
    of agreement 
	 	 	 
	 	 	Company
    B shall not assign its rights and/or obligations under the Agreement to any third party except with the prior written consent of
    Company A.
	 	 	 
	 	13.7.	Severability
    of the Agreement
	 	 	 
	 	 	If
    any provision of the Agreement is invalid or unenforceable due to inconsistency with pertinent laws, such provision shall be invalid
    or unenforceable only within the jurisdiction of pertinent laws, and it shall not affect the legal effect of other provisions hereof.
	 	 	 
	 	13.8.	Abstention
    
	 	 	 
	 	 	Either
    party may abstain from the terms and conditions hereof. The abstention shall only be effective when made in writing and signed by
    both parties. The abstention of one party caused by the breach of the other under certain circumstances shall not be deemed as abstention
    of a similar breach of contract by that party under other circumstances.
	 	 	 
	 	13.9.	Amendment
    and supplement to the Agreement 
	 	 	 
	 	 	Both
    parties shall amend and supplement the Agreement by written agreement. The amended and supplemented agreement related to the Agreement
    signed by both parties are integral parts hereof and have the same legal effect as the Agreement.
	 	 	 
	 	13.10.	Agreement
    text 
	 	 	 
	 	 	The
    Agreement is written in Chinese and signed in duplicate. Each party shall keep one. In witness whereof, the parties have their authorized
    representatives signed the Agreement on the date indicated at the beginning of the Agreement. 

 

[No
text below]

 

    	14/17

    	 

    

 

	Chengdu
    Jiulin Ke Fu Technological Co., Ltd. (seal)	 
	 	 	 
	Signature:	 	 
	Name:	Jiulin
    Zhang	 
	Title:	 Legal
    Representative 	 
	 	 	 
	Sichuan
    Hengguang Insurance Agency Co., Ltd. (seal)	 
	 	 	 
	Signature:	 	 
	Name:
    	Chunling
    Mao	 
	Title:	legal
    representative	 

 

    	15/17

    	 

    

 

Annex
1: Management Consulting and Service Contents

 

Company
A shall provide Company B with the following management consulting and services:

 

	 	(1)	Provide
    development strategy and planning involved in developing insurance agency business of Company B (including but not limited to the
    acquisition of equity of other insurance brokers, the establishment of insurance assessment institutions, etc.), management of APP
    technology in developing insurance agency products, information application on related operation platforms, customer classification,
    overall solution of agency business and company management and consultation, etc.;
	 	 	 
	 	(2)	Provide
    relevant technology application and implementation services for the operation of Company B’s insurance agency business, including
    but not limited to property insurance of, for example, HengKuaiBao insurance APP (auto insurance, non-auto insurance), life insurance
    and software application, system integration as well as their installation, debugging and trial operation of the supermarket functions
    featuring the purchase, marketing and promotion of insurance products which are available for online customers, promotion members
    and insurance agents;
	 	 	 
	 	(3)	For
    Company’s advertising operation, provide it with technical services such as advertising design, software design and page production,
    and provide suggestions for its management consulting;
	 	 	 
	 	(4)	Take
    charge of the daily maintenance and monitoring of Company B’s brand promotion (including information database) and marketing,
    and provide other related consulting services;
	 	 	 
	 	(5)	Provide
    consulting services for Company B to purchase equipment, software and hardware systems needed for the application of its online platform,
    including but not limited to put forward suggestions on the selection of various tools, applications and technical platforms, on
    system installation and debugging, and on the purchase, model and performance of various matching hardware facilities and equipment;
	 	 	 
	 	(6)	Provide
    financial consultation on the questions and settlement of financial subjects and account books d by Company B, so as to make the
    financial treatment of Company B conform to the standards and requirements of American finance and audit;
	 	 	 
	 	(7)	Provide
    staff training and technical support and assistance to Company B, including but not limited to providing appropriate training to
    Company B and its employees, including after-sales or technical service for customers and insurance products; introduce the knowledge
    and experience of system and equipment installation and operation to Company B and its employees so as to enable them to solve the
    problems that occur at any time during the process of system and equipment installation and operation; provide consultation and suggestions
    on other online editing platforms and software to Company B, and assist it in compiling and collecting various kinds of information;
	 	 	 
	 	(8)	Provide
    other consultation services based on Company B’s operation needs

 

[No
text below]

 

    	16/17

    	 

    

Annex
2: Calculation and Payment of Management Consulting and Service 

 

	1.	The
    amount of service fee shall be determined according to the following factors: 
	 	 	 
	 	(1)	The
    difficulty of strategic development planning and the complexity of consulting and management services;
	 	 	 
	 	(2)	The
    time required for Company A to provide such consulting and management services; and 
	 	 	 
	 	(3)	The
    specific content and commercial value of consulting and management services.

 

	2.	Company
    A shall bill Company A quarterly in accordance with the workload and commercial value of the technical services provided by it to
    Company B and the price agreed by both parties; Company B shall pay Company A the corresponding consulting service fee according
    to the date and amount specified in the bill. Company A has the right to adjust the standard of consulting service fee at any time
    according to the quantity and content of consulting services it provides to Company B. The above adjusted consulting service fee
    shall be under the approval of Company A.
	 	 
	3.	Company
    B shall establish and implement accounting system and prepare financial statements in accordance with relevant laws, regulations,
    accounting system and accounting standards of China. Should Company A require, Company B shall prepare separate financial statements
    in accordance with American accounting standards or other accounting standards otherwise required by Company A. Company B shall,
    within 15 days after the end of each calendar month, provide Company A with its financial statements, operation records, business
    contracts and financial information, as well as other reports required by Company A, so that Company A can calculate the amount of
    service fee payable by Company A to it in accordance with the above provisions. Company A has the right to audit all the financial
    statements and other relevant information of Company B at any working time on condition that it notifies Company B in advance within
    a reasonable time. Should Company A question the financial information provided by Company A, it may appoint an independent accountant
    with good reputation to audit the relevant information hereto, and Company B shall cooperate.

 

[No
text below]

 

    	17/17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]